SpyGlass Pharma logo

SpyGlass Pharma

SGP | NASDAQ
Chart Builder DCF Calculator
$32.24
-$0.64 (-1.95%)
At close: Nov 16, 2026, 4:00 PM ET
$32.24
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.95%

Rating

Updated: Nov 16, 2026
24.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #948/1021 (Top 93%)

Key Statistics

Market Data

Market Cap $1.08B
1D Range
29.16 32.81
52W Range
17.56 38.37

Valuation (TTM)

PE -13.49
PB 5.13
EV/EBITDA -11.73

Valuation (NTM)

Forward PE N/A
Forward PEG -0.37
Price Target $39.00
Loading financial charts...

Profile

SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigati...

Sector Healthcare
Industry Biotechnology
Employees 76
IPO Date Feb 6, 2026
Fiscal Year January - December

Latest News

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

5 days ago · globenewswire.com

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
SpyGlass Pharma to Participate in Upcoming Investor Conferences

12 days ago · globenewswire.com

SpyGlass Pharma to Participate in Upcoming Investor Conferences

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$39.00
Upside
+20.97%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.